Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).

@article{Penniment2018PalliativeCV,
  title={Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).},
  author={Michael Gordon Penniment and Paolo B De Ieso and Jennifer A. Harvey and Sonya Stephens and H J Au and Christopher James O'Callaghan and Andrew Kneebone and Samuel Y.K. Ngan and Iain G Ward and Rajarshi Roy and Jennifer G Smith and Tirath Nijjar and James Joseph Biagi and Liam A Mulroy and Rebecca K. S. Wong},
  journal={The lancet. Gastroenterology & hepatology},
  year={2018},
  volume={3 2},
  pages={
          114-124
        }
}
BACKGROUND A short course of radiotherapy is commonly prescribed for palliative relief of malignant dysphagia in patients with incurable oesophageal cancer. We compared chemoradiotherapy with radiotherapy alone for dysphagia relief in the palliative setting. METHODS This multicentre randomised controlled trial included patients with advanced or metastatic oesophageal cancer who were randomly assigned (1:1) through a computer-generated adaptive biased coin design to either palliative… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 20 times over the past 90 days. VIEW TWEETS